NCT05563298View on ClinicalTrials.gov

Neuro RX Gamma for Amnestic Mild Cognitive Impairment (aMCI)

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 28, 2023

Primary Completion Date

February 3, 2025

Study Completion Date

February 3, 2025

Conditions
MCIAmnestic Mild Cognitive Disorder
Interventions
DEVICE

Neuro RX Gamma device

The Neuro RX Gamma device is a portable, wearable, low level light therapy (LLLT) delivery device. The Vielight Neuro RX Gamma delivers a synchronized pulse frequency of 40 Hz from all LED clusters.

DEVICE

Sham Neuro RX Gamma device

The Sham device is indistinguishable from the active device. The sham device will not deliver light for the 20 minutes session duration.

Trial Locations (1)

M5B 1W8

St Michael's Hospital, Toronto

All Listed Sponsors
lead

Unity Health Toronto

OTHER